Volume 152, Issue 1, Pages (January 2019)

Slides:



Advertisements
Similar presentations
ABO-incompatible kidney transplantation Kota Takahashi, Kazuhide Saito Transplantation Reviews Volume 27, Issue 1, Pages 1-8 (January 2013) DOI: /j.trre
Advertisements

Curative Treatment of Stage I Non-Small-Cell Lung Cancer in Patients With Severe COPD: Stereotactic Radiotherapy Outcomes and Systematic Review  David.
Volume 144, Issue 1, Pages (January 2017)
Referral patterns between high- and low-volume centers and associations with uterine cancer treatment and survival: a population-based study of Medicare,
Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade.
Volume 148, Issue 1, Pages (January 2018)
Log odds of positive lymph nodes is a superior prognostic indicator in stage III rectal cancer patients: A retrospective analysis of 17,632 patients in.
Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non–Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database  Alex.
Volume 148, Issue 1, Pages (January 2018)
Volume 64, Issue 5, Pages (November 2013)
Are patients willing to travel for better ovarian cancer care?
Volume 148, Issue 1, Pages (January 2018)
L. C. Parsons, S. A. Sullivan, C. Garcia, T. Castellano, V. L
Volume 148, Issue 1, Pages (January 2018)
Volume 146, Issue 3, Pages (September 2017)
A. Melamed, E. J. Diver, A. A. Gockley, E. M. Hinchcliff, L
Volume 145, Issue 2, Pages (May 2017)
Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non–Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database  Alex.
Vulvar intraepithelial neoplasia: Risk factors for recurrence
Corrigendum to “MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer” [Gynecologic Oncology 110: 13–21, 2008]  Douglas.
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 
Volume 144, Issue 2, Pages (February 2017)
Patterns of Care and Treatment Outcomes of Elderly Patients with Stage I Esophageal Cancer: Analysis of the National Cancer Data Base  Amy C. Moreno,
Patient-reported symptoms and performance status before palliative radiotherapy in geriatric cancer patients (octogenarians)  Carsten Nieder, Thomas A.
Volume 141, Issue 2, Pages (May 2016)
IA05.01 Lung Cancer Cases Journal of Thoracic Oncology
Volume 71, Issue 5, Pages (May 2017)
Wilberto Nieves-Neira, J. Julie Kim, Daniela Matei 
Volume 152, Issue 1, Pages (January 2019)
National trends in management of stage IIIC1 and IIIC2 uterine cancer: Chemotherapy and radiotherapy in isolation and sequence  J. Chino, J.R. Foote,
Volume 146, Issue 1, Pages (July 2017)
Volume 151, Issue 1, Pages (October 2018)
K. Bixel, N. Denlinger, L. Marsh, A. Quick, R. Salani
Volume 152, Issue 1, Pages (January 2019)
Volume 152, Issue 1, Pages (January 2019)
Laparoscopic staging for stage I epithelial ovarian cancer: Analysis of the National Cancer Data Base  A. Melamed, J.T. Clemmer, N.L. Keating, J.D. Wright,
Impact of Positive Nodal Metastases in Patients with Thymic Carcinoma and Thymic Neuroendocrine Tumors  Benny Weksler, MD, Anthony Holden, MD, Jennifer.
Effects of Chemotherapy on Survival of Elderly Patients with Small-Cell Lung Cancer: Analysis of the SEER-Medicare Database  Laura C. Caprario, MD, MS,
Erik Jakobsen, Maria Iachina, Karen Ege Olsen, Anders Green 
Comparing the health and economic impacts of cervical cancer screening strategies using the Cancer Risk Management Model (CRMM)  C. Popadiuk, A.J. Coldman,
I. Mert, A. R. Munkarah, R. K. Hanna, J. Chhina, M. S. Carey, M
Ellen Kim, MD, MPH, Siran Koroukian, PhD, Charles R. Thomas, MD 
Volume 152, Issue 1, Pages (January 2019)
Are ovarian cancer debulking models reliable: Variance and predictability are dependent on institutional optimal debulking rates  N.A. Latif, E.M. Ko,
Pharmacokinetics of Gefitinib Predicts Antitumor Activity for Advanced Non-small Cell Lung Cancer  Yoichi Nakamura, MD, PhD, Kazumi Sano, PhD, Hiroshi.
Volume 152, Issue 1, Pages (January 2019)
Volume 147, Issue 1, Pages (October 2017)
Volume 152, Issue 1, Pages (January 2019)
Limited access safety lead-in of the MEK inhibitor trametinib in combination with GSK , an AKT inhibitor, in patients with recurrent or persistent.
Perineural invasion (PNI) in vulvar carcinoma: A review of 421 cases
Outcomes After Transhiatal and Transthoracic Esophagectomy for Cancer
Volume 142, Issue 2, Pages (August 2016)
Annika Idahl, Andrea Hermansson, Ann Lalos  Gynecologic Oncology 
Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival: an NRG Oncology/Gynecologic Oncology Group study 
Is the B12/CRP Index More Accurate Than You at Predicting Life Expectancy in Advanced Cancer Patients?  Filipa Tavares, MD  Journal of Pain and Symptom.
Volume 130, Issue 1, Pages (July 2013)
Full inguinofemoral lymphadenectomy after positive sentinel inguinofemoral lymph node is associated with greater overall survival in patients with stage.
Volume 152, Issue 1, Pages (January 2019)
Volume 151, Issue 1, Pages (October 2018)
Upregulated Wnt signaling is associated with increased survival of patients with high- grade serous ovarian cancer  M. Dandapani, B.L. Seagle, R. Samuelson,
Volume 130, Issue 1, Pages (July 2013)
Interferon alfa-2a for melanoma metastases
Michael Hsie, MD, Stefania Morbidini-Gaffney, MD, Leslie J
Volume 152, Issue 1, Pages (January 2019)
High-risk cancer, unequal care: Disparities in the complete surgical staging of high- grade endometrial cancer in the Southeastern United States  J.R.
Volume 115, Issue 1, Pages (October 2009)
Volume 152, Issue 3, Pages (March 2019)
Surveillance Epidemiology and End Results Evaluation of the Role of Surgery for Stage I Small Cell Lung Cancer  James B. Yu, MD, Roy H. Decker, MD, PhD,
Volume 154, Issue 1, Pages (July 2019)
Presentation transcript:

Volume 152, Issue 1, Pages 119-126 (January 2019) Missing information in statewide and national cancer databases: Correlation with health risk factors, geographic disparities, and outcomes  Mackenzie W. Sullivan, Fabian T. Camacho, Anne M. Mills, Susan C. Modesitt  Gynecologic Oncology  Volume 152, Issue 1, Pages 119-126 (January 2019) DOI: 10.1016/j.ygyno.2018.10.029 Copyright © 2018 Elsevier Inc. Terms and Conditions

Fig. 1 Kaplan-Meier curves showing overall survival stratified by grade in the (A) UVA sample and (B) SEER sample. Gynecologic Oncology 2019 152, 119-126DOI: (10.1016/j.ygyno.2018.10.029) Copyright © 2018 Elsevier Inc. Terms and Conditions

Fig. 2 Maps of Virginia showing missing grade correlated with (A) female obesity prevalence and (B) female smoking prevalence. Moran's plots are presented below. 2A: Moran's I: 0.103, p = 0.017. 2B: Moran's I: 0.181, p = 0.001. Gynecologic Oncology 2019 152, 119-126DOI: (10.1016/j.ygyno.2018.10.029) Copyright © 2018 Elsevier Inc. Terms and Conditions

Fig. 3 Map of Virginia with (A) missing stage and (B) missing grade. Gynecologic Oncology 2019 152, 119-126DOI: (10.1016/j.ygyno.2018.10.029) Copyright © 2018 Elsevier Inc. Terms and Conditions